RNASE2 and neoplasm: In a GBM model, EDN, a ligand of toll-like receptor-2 (TLR2) that can induce immune cells to infiltrate tumor tissue and inhibit tumor growth [28, 29], may be favorable for inhibiting GBM cells [21].